Completion of rights issue and capital increase


On November 11, 2016, The Board of Directors of BioPorto A/S (BioPorto) decided to partially exercise the authorization in the Company Articles article 16b to make a direct placement to a limited number of institutional and financial investors, cf. company announcement no. 21 of November 11, 2016. As announced in company announcement no. 22 of November 14, 2016, the rights issue was fully subscribed.

Completion of the rights issue

BioPorto A/S has now received the full subscription amount, and today the company has procured that the capital increase of in total nominally DKK 12,895,096 has been registered with the Danish Business Authority.

BioPorto A/S’ gross proceeds from the rights issue amount to DKK 21.8 million. The aggregate net proceeds amount to DKK 20.8 million after deduction of costs for the completion of the rights issue.

Admission to trading and official listing

The new shares will as soon as possible be admitted to trading and official listing on Nasdaq Copenhagen A/S under the ISIN code of the company’s existing shares (ISIN DK0011048619), which is expected to take place on November 22, 2016.

Share capital after the rights issue

As a result of the rights issue, BioPorto A/S’ share capital has been increased by nominally DKK 12,895,096. Accordingly, the total share capital of BioPorto A/S now amounts to DKK 142,494,056 divided into 142,494,056 shares of nominally DKK 1 each, equivalent to 142,494,056 votes. BioPorto A/S’ articles of association have been updated accordingly and are available on the company’s website.

 

For further information please contact:

Peter Mørch Eriksen, CEO

Christina Thomsen, Investor relations

Tel.: 45 29 00 00, e-mail investor@bioporto.com


Attachments

24 announcement 2016 11 18.pdf